Treatment with DPPIV inhibitors may contribute to the prevention of T1D.
Expression of immune –related genes is modified in the thymi of NOD mice by MK626.
MK626 treatment increases the expression of genes involved in central tolerance.
DPPIV inhibitor treatment does not alter β-cell autoantigens and Aire expression in TECs.